Displaying drugs 201 - 225 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Infliximab | 144190.3 C6428H9912N1694O1987S46 |  | A monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Inotuzumab ozogamicin | Not Available |  | An antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL). | Antibodies, Monoclonal / CD22 (Clusters of Differentiation 22) inhibitors |
| Insulin aspart | 5825.8 C256H381N65O79S6 |  | A rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin beef | C254H377N65O75S6 | | Insulin beef has been discontinued in the US and Canada since 2017. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin degludec | 6103.97 C274H411N65O81S6 |  | A long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus. | Insulin Analog |
| Insulin detemir | 5916.9 C267H402N64O76S6 |  | A long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Blood Glucose Lowering Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin glargine | 6063.0 C267H404N72O78S6 |  | A modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Hypolipidemic Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin glulisine | 5823.0 C258H384N64O78S6 | | A short-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin human | 5808.0 C257H383N65O77S6 |  | A recombinant form of human insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Insulins and Analogues for Injection, Fast-Acting |
| Insulin lispro | 5808.0 C257H387N65O76S6 |  | A modified form of fast-acting insulin used to control hyperglycemia in diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin pork | 5795.6 C257H387N65O76S6 |  | A purified form of porcine insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Insulins and Analogues for Injection, Fast-Acting |
| Interferon alfa-2a | 19241.1 C860H1353N227O255S9 |  | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. | Interferons |
| Interferon alfa-2b | 19271.0 C860H1353N229O255S9 |  | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. | Antineoplastic Agents / Antiviral Agents / Drugs causing inadvertant photosensitivity / Interferon alpha / Interferon-alpha / Interferons |
| Interferon alfa-n1 | 19241.1 C860H1353N227O255S9 |  | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus. | Interferons |
| Interferon alfa-n3 | Not Available |  | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus. | Interferon alpha |
| Interferon alfacon-1 | 19343.0 C860H1353N227O255S9 |  | A recombinant interferon similar the interferon alfa subtype which is used to treat hepatitis C infections. | Interferons |
| Interferon beta-1a | 20027.0 C908H1408N246O252S7 |  | A form of recombinant human interferon used to slow disease progression and reduce the frequency of clinical symptoms in patients who have relapsing multiple sclerosis. | Interferons |
| Interferon beta-1b | 20011.0 C908H1408N246O253S6 |  | A form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms. | Interferons |
| Interferon gamma-1b | 17145.6 C761H1206N214O225S6 |  | A form of recombinant human interferon used to treat infections associated with chronic granulomatous disease and to slow the progression of severe malignant osteopetrosis. | Interferon gamma |
| Ipilimumab | 148000.0 C6572H10126N1734O2080S40 |  | A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. | Antibodies, Monoclonal |
| Isatuximab | 148000.0 | | A chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies. | CD38 (Clusters of Differentiation 38) inhibitors |
| Ixekizumab | 146158.0 C6492H10012N1728O2028S46 | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Keyhole limpet hemocyanin | Not Available | | Investigated for use/treatment in bladder cancer and solid tumors. | Adjuvants, Immunologic / Antigens / Mollusca |
| Lanadelumab | 146000.0 C6468H10016N1728O2012S47 |  | A monoclonal antibody targeted against kallikrein which is used to treat attacks of hereditary angioedema. | Drugs Used in Hereditary Angioedema |
| Laronidase | 69899.4 C3160H4848N898O881S12 |  | A form of recombinant human alpha-L-iduronidase used to treat Hurler and Hurler-Scheie forms of mucopolysaccharidosis, a genetic deficiency of alpha-L-iduronidase. | Enzymes / Glycoside Hydrolases / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme / Iduronidase, antagonists & inhibitors |
Displaying drugs 201 - 225 of 406 in total